Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_assertion wasGeneratedBy ECO_0000203 NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_assertion wasDerivedFrom befree-20150227 NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_assertion SIO_000772 23762470 NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_assertion evidence source_evidence_literature NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.
- NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_assertion description "[Medications which target specifically the ACE2/Ang-(1-7)/Mas axis may offer new therapeutic opportunities to treat human nephropathies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238089.RAXgs5aBz5Ffy3a5BzR498H11p1Yv26X2dA5rYHJxmPlA130_provenance.